NEWS

Apr 5, 2019
NIH observed rare disease day on 28th February 2019 to build commitment in helping people with rare diseases through research at National Center for Advancing Translational Sciences (NCATS) and Clinical Center (CC). NCATS selected eleven honorable...
Apr 5, 2019
Tick-borne diseases are emerging as a serious public health problem in the United States. Ticks transmit different infectious diseases including Lyme disease, Rocky Mountain spotted fever and babesiosis. According to CDC, there is more than 30,000...
Feb 26, 2019
A research team, led by Dennis Drayna, Ph.D., chief of the Section on Genetics of Communication Disorders at the National Institute on Deafness and Other Communication Disorders (NIDCD), conducted detailed genetic analyses on 1,300 adults. A genetic...

New & Updated Opportunities

Apr 25, 2019

Mesothelioma is an aggressive cancer covering anatomic surfaces (e.g. lining of the lungs, heart, abdomen, etc.) that resists multi-modality therapies. Regional...

Apr 23, 2019

The chemokine receptor CCR4 is a seven-transmembrane G protein-coupled cell surface receptor molecule with selective expression on cells of the hematopoietic system. In...

Apr 15, 2019

The simultaneous concentration and recovery of microbes in drinking water is important for responding to potential water-related events such as pathogen contamination...

SPOTLIGHT

The Cure Sickle Cell Initiative was launched by the National Heart, Lung, and Blood Institute (NHLBI) to build a nationwide commitment in finding new treatments and personalized care for this hereditary red blood cell disorder. Sickle cell disease affects about 100,000 Americans, many of whom are African American, and over 20 million people worldwide. Since founded in 1948, NHLBI has the long tradition of advancing research on understanding of the sickle cell disease and improving its clinical care. NHLBI also offers many sickle cell disease resources, including publications and videos to help patients and health professionals to learn about treatment and pain management strategies.

Cure Sickle Cell Initiative will actively engage and positively motivate the sickle cell disease community of patients, family members, caregivers, academic institutions, advocacy groups, pharmaceutical companies, federal agencies and biotechnology companies to work together on a path to...

Read More...